An apparent danazol-induced primary hepatocellular carcinoma: case report
This case report describes an apparent danazol-induced primary hepatocellular carcinoma in a 49-year-old patient treated continuously for two years with the pituitary gonadotrophin inhibitor, where tumor regression did not occur after drug discontinuation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (5)
- doi:10.1016/s0140-6736(75)91494-4 via openalex
- doi:10.1136/bmj.2.6138.661 via openalex
- doi:10.1136/jcp.32.10.971 via openalex
- doi:10.1111/j.1365-2559.1977.tb01663.x via openalex
- doi:10.1111/j.1365-3083.1978.tb03904.x via openalex
Cited by (10)
- Danazol induced acute icteric cholestatic hepatitis 2007
- Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions 2004
- Danazol-induced hepatocellular carcinoma 2003
- Hepatocellular adenoma and focal nodular hyperplasia after long-term use of danazol for endometriosis: a case report 2002
- [Danazol-induced hepatitis with functional deficit of the C1 inhibitor] 2001
- Danazol therapy: an unusual aetiology of hepatocellular carcinoma 1998
- Danazol for paroxysmal nocturnal hemoglobinuria 1997
- Ultrastructural features of danazol-induced cholestasis: a case study 1996
- Danazol-induced hepatocellular adenoma 1990
- Danazol and cholestatic hepatitis 1986
Source provenance
- openalex
- last seen: 2026-05-13T18:27:55.367740+00:00
- pubmed
- last seen: 2026-10-08T21:15:13.843571+00:00